PHARMAESSENTIA CORP.
Area: Pharmaceutical and Medical Devices
Booth No: R607
Website: http://www.pharmaessentia.com
Exhibitor Profile
PharmaEssentia (Taipei Exchange: 6446) develops treatments for myeloproliferative neoplasms and other diseases. Its cGMP biologics facility in Taichung is certified by EMA and TFDA.
Development and Indications
− Ropeginterferon alfa-2b: Polycythemia Vera (PV), Essential Thrombocythemia (ET)
− Oraxol: Breast Cancer
− Oraxol+Ramucirumab: Gastric Cancer
− KX01: Psoriasis, Actinic Keratosis
Brands
Ropeginterferon alfa-2b
Exhibit Products
Exhibitors you may be interested in
Highest Rated
-
FORMOSA BIOMEDICAL TECHNOLOGY CORP.
-
SUNTEX INSTRUMENTS CO., LTD.
-
ADIMMUNE CORPORATION
-
NTU SPARK PROGRAM
-
CHANG GUNG UNIVERSITY
-
PHARMAESSENTIA CORP.
-
SYNCORE BIOTECHNOLOGY CO., LTD.
-
GOLDEN BIOTECHNOLOGY CORP.
-
GENEREACH BIOTECHNOLOGY CORP.
-
CHUNG YUAN CHRISTIAN UNIVERSITY
-
BRISTOL MYERS SQUIBB (TAIWAN) LTD.
-
ROCHE PRODUCTS LTD., TAIWAN
-
CHINA MEDICAL UNIVERSITY AND HEALTHCARE SYSTEM
-
TAIPEI MEDICAL UNIVERSITY
-
MINISTRY OF HEALTH AND WELFARE
-
E2JOY CORPORATION
-
NATIONAL YANG-MING UNIVERSITY INNOVATION AND INCUBATION CENTER
-
GLOBAL RESEARCH & INDUSTRY ALLIANCE, NATIONAL CHENG KUNG UNIVERSITY
-
QUARK BIOSCIENCES, INC.
-
FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE
-
NATIONAL CHUNG HSING UNIVERSITY
-
MEDICAL AND PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT CENTER
-
NATIONAL TSING HUA UNIVERSITY GLOBAL RESEARCH & INDUSTRY ALLIANCE
-
ONLY SCIENCE CO., LTD.
-
FORESEE PHARMACEUTICALS CO., LTD.
-
WENDY INTERNATIONAL LTD
-
PHARMACORE BIOTECH CO., LTD
-
FORMOSA LABORATORIES, INC.
-
LUKAS BIOMEDICAL INC.
-
NATIONAL CHIAO TUNG UNIVERSITY
